share_log

Short Interest in BetterLife Pharma Inc. (OTCMKTS:BETRF) Declines By 20.5%

Short Interest in BetterLife Pharma Inc. (OTCMKTS:BETRF) Declines By 20.5%

空頭股數在BetterLife製藥公司(場外交易代碼：BETRF)下跌20.5%
Defense World ·  2022/08/04 16:11

BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Rating) saw a large drop in short interest in the month of July. As of July 15th, there was short interest totalling 57,100 shares, a drop of 20.5% from the June 30th total of 71,800 shares. Based on an average trading volume of 47,100 shares, the days-to-cover ratio is currently 1.2 days.

美好生活製藥公司(BetterLife Pharma Inc.)7月份的空頭股數銷量大幅下降。截至7月15日，空頭股數共有57,100股，較6月30日的71,800股下降20.5%。以47,100股的平均成交量計算，目前天數與回補比率為1.2天。

BetterLife Pharma Price Performance

BetterLife Pharma價格表現

OTCMKTS BETRF opened at $0.11 on Thursday. The company has a market cap of $5.52 million, a P/E ratio of -0.89 and a beta of 2.90. The stock has a 50-day moving average of $0.09 and a two-hundred day moving average of $0.11. BetterLife Pharma has a 1-year low of $0.05 and a 1-year high of $0.30.

OTCMKTS BETRF週四開盤報0.11美元。該公司市值552萬美元，市盈率為-0.89，貝塔係數為2.90。該股的50日移動均線切入位在0.09美元，200日移動均線切入位在0.11美元。BetterLife Pharma的一年低點為0.05美元，一年高位為0.30美元。

Get
到達
BetterLife Pharma
BetterLife製藥公司
alerts:
警報：

BetterLife Pharma (OTCMKTS:BETRF – Get Rating) last posted its quarterly earnings data on Tuesday, June 28th. The company reported ($0.03) EPS for the quarter.

BetterLife Pharma(OTCMKTS：BETRF-GET Rating)最近一次公佈季度收益數據是在6月28日(星期二)。該公司公佈了該季度每股收益(0.03美元)。

About BetterLife Pharma

關於BetterLife Pharma

(Get Rating)
(獲取評級)

BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of neurological disorders in Canada and internationally. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections.

BetterLife製藥公司是一家生物技術公司，在加拿大和國際上從事治療神經疾病的化合物的開發和商業化。它參與從一系列基於幹擾素的互補技術中提煉和開發候選藥物，這些技術有可能讓免疫系統參與抗擊病毒感染。

Further Reading

進一步閲讀

  • Get a free copy of the StockNews.com research report on BetterLife Pharma (BETRF)
  • There Are Different Types of Stock To Invest In
  • Is it Time to Tap Molson Coors or Will Beer Sales Turn Flat?
  • PayPal Continues To Struggle As Competition Increases
  • Is Starbucks Shooting For The Moon?
  • Two High-Yield Deep-Values You Shouldn't Ignore
  • 免費獲取StockNews.com關於BetterLife Pharma的研究報告(BETRF)
  • 有不同類型的股票可供投資
  • 是時候開發Molson Coors了，還是啤酒銷售會變得平淡？
  • PayPal繼續掙扎，競爭加劇
  • 星巴克是在向月球進軍嗎？
  • 你不應該忽視的兩個高收益深度價值

Receive News & Ratings for BetterLife Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BetterLife Pharma and related companies with MarketBeat.com's FREE daily email newsletter.

接受BetterLife Pharma Daily的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對BetterLife Pharma和相關公司的最新新聞和分析師評級的每日簡要摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論